Referenced in: none

Automatically associated channels: Kv10.1 , Kv11.1 , Slo1

Title: Structural determinants for high-affinity block of hERG potassium channels.

Authors: John Mitcheson, Matthew Perry, Phillip Stansfeld, Michael C Sanguinetti, Harry Witchel, Jules Hancox

Journal, date & volume: Novartis Found. Symp., 2005 , 266, 136-50; discussion 150-8

PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/16050266

Abstract
Drug-induced long QT syndrome is an abnormality of cardiac action potential repolarization that can induce arrhythmias and sudden death. This unwanted side effect of some medications is most frequently associated with block of hERG channels, even though it could theoretically result from inhibition of any K+ current with a role in repolarization. Recent studies suggest an explanation for why so many structurally diverse compounds preferentially block hERG. State dependent inhibition of hERG channel currents and slow kinetics for recovery from block suggest that many drugs bind within the inner cavity of the channel and are trapped by closure of the activation gate upon repolarization. Drug trapping studies indicate that the inner cavity of hERG is larger than other voltage-gated K+ channels. Scanning Ala mutagenesis of S6 and pore helix domains that line the inner cavity of hERG have demonstrated that two aromatic residues (Tyr652 and Phe656) are important sites of interaction for most blockers investigated so far. These residues are unique to the EAG channel family. Ser624 and Thr623 residues at the base of the pore helices are also critical for high-affinity binding for some compounds (e.g. methanesulfonanilides) but not others (cisapride, terfenadine, propafenone).